Drug intelligence / Profile preview

xiaosheng powder

Development stage: Unknown
Lead developer: Eye Hospital, China Academy of Chinese Medical Sciences
Administration: Oral

Overview

Xiaosheng Powder is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Eye Hospital of the China Academy of Chinese Medical Sciences. It is primarily investigated for the treatment of dry eye syndrome (keratoconjunctivitis sicca), specifically in patients presenting with the TCM patterns of liver depression and Yin deficiency. The formulation is typically administered orally as granules and has been evaluated in clinical trials as an adjunct therapy to standard 0.3% sodium hyaluronate eye drops. Its therapeutic approach is rooted in TCM principles, aiming to address systemic imbalances believed to contribute to ocular surface dryness and tear film instability.

Other names: Xiaosheng PowderXiaosheng San消眚散

Beyond the preview

Go deeper on xiaosheng powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiaosheng powder.

Explore the full profile